Concourse Financial Group Securities, Inc. Alpha Tau Medical Ltd. Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding DRTS
# of Institutions
27Shares Held
1.39MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY315KShares$915,2350.1% of portfolio
-
Hoyle Cohen, LLC269KShares$783,0460.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$671,3480.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$193,0080.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$155,9930.04% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $201M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...